(NASDAQ: FTRE) Fortrea Holdings's forecast annual revenue growth rate of 0.08% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.86%.
Fortrea Holdings's revenue in 2025 is $2,733,500,000.On average, 14 Wall Street analysts forecast FTRE's revenue for 2025 to be $242,280,000,000, with the lowest FTRE revenue forecast at $216,090,000,000, and the highest FTRE revenue forecast at $254,520,000,000. On average, 14 Wall Street analysts forecast FTRE's revenue for 2026 to be $241,200,000,000, with the lowest FTRE revenue forecast at $222,390,000,000, and the highest FTRE revenue forecast at $254,250,000,000.
In 2027, FTRE is forecast to generate $248,130,000,000 in revenue, with the lowest revenue forecast at $227,610,000,000 and the highest revenue forecast at $265,410,000,000.